Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients

Clinical Infectious Diseases

Volumn 38, Issue 10, 2004, Pages 1428-1439

  Doucette, Karen ^a   Fishman, Jay A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CALCINEURIN INHIBITOR; CASPOFUNGIN; CEFEPIME; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZAMINE; CYCLOSERINE; CYCLOSPORIN; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; GANCICLOVIR; KANAMYCIN; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXICIN; PREDNISONE; RIFABUTIN; RIFAMPICIN; STEROID; STREPTOMYCIN; SULFONAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIOPSY; BLOOD CULTURE; CATHETER; FUNGUS; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; NOCARDIA; PRIORITY JOURNAL; RECIPIENT; REVIEW; SKIN DEFECT; STAINING;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM INFECTIONS; PROGNOSIS; TRANSPLANTATION;

EID: 2542468035     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/420746     Document Type: Review

References (151)

1. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107-59.
2. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135:1007-14.
3. Young LS, Inderlied CB, Berlin OG, Gottlieb MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986; 8:1024-33.
4. Horsburgh CR Jr, Mason UG, 3rd, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare: a report of 13 cases and a review of the literature. Medicine (Baltimore) 1985; 64:36-48.
5. Wallace RJ Jr, Zhang Y, Brown BA, et al. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998; 158:1235-44.
6. Kubo K, Yamazaki Y, Hachiya T, et al. Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease. Lung 1998; 176:381-91.
7. Arslan H, Oner-Eyuboglu F, Kalpaklioglu F, et al. Mycobacterial infections in solid organ transplant recipients. Transplant Proc 1999; 31:3197-8.
8. Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994; 106:435-9.
9. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17:274-83.
10. Munoz P, Palomo J, Munoz R, Rodriguez-Creixems M, Pelaez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21:398-402.
11. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-77.
12. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19:467-70.
13. Novick RJ, Moreno-Cabral CE, Stinson EB, et al. Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant 1990; 9:357-63.
14. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999; 160:1611-6.
15. Navari RM, Sullivan KM, Springmeyer SC, et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36:509-13.
16. Butler WR CJ. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States, 1993-1996. Atlanta, GA: Centers for Disease Control and Prevention, 1999:1-51.
17. Gaviria JM, Garcia PJ, Garrido SM, Corey L, Boeckh M. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6:361-9.
18. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77:35-40.
19. Weinstock DM, Feinstein MB, Sepkowitz KA, Jakubowski A. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31:1015-21.
20. Lloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients: seven cases and a review of the literature. Arch Intern Med 1982; 142:888-92.
21. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25:2288-9.
22. Costa JM, Meyers AM, Botha JR, Conlan AA and Myburgh A. Mycobacterial infections in recipients of kidney allografts: a seventeen-year experience. Acta Med Port 1988; 1:51-7.
23. Higgins RM, Cahn AP, Porter D, et al. Mycobacterial infections after renal transplantation. Q J Med 1991; 78:145-53.
24. Vandermarliere A, Van Audenhove A, Peetermans WE, Vanrenterghem Y, Maes B. Mycobacterial infection after renal transplantation in a Western population. Transpl Infect Dis 2003; 5:9-15.
25. Spence RK, Dafoe DC, Rabin G, et al. Mycobacterial infections in renal allograft recipients. Arch Surg 1983; 118:356-9.
26. Munoz RM, Pulpon LA, Yebra M, Segovia J, San Martin M, Salas C. Three cases of tuberculosis after heart transplantation in Spain. Eur J Clin Microbiol Infect Dis 1998; 17:801-6.
27. Kesten S, Chaparro C. Mycobacterial infections in lung transplant recipients. Chest 1999; 115:741-5.
28. Higgins RSD Kocoshis S, Reyes J, et al. Mycobacerium tuberculosis after liver transplantation: management and guidelines for prevention. Clin Transplant 1992; 6:81-90.
29. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Reply [letter]. Am J Med 1985; 79:A120.
30. Cryer PE KJ. Pulmonary and hepatic disease after chemotherapy and bone marrow transplantation for acute leukemia. Am J Med 1979; 66:484-94.
31. Okano A, Shimazaki C, Ochiai N, et al. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28:709-11.
32. Peters EJ, Morice R. Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest 1991; 100:1449-50.
33. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119:482-6.
34. White MH, Papadopoulos EB, Small TN, Kiehn TE, Armstrong D. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 1995; 60:957-60.
35. Armstrong D, Kiehn T, Boone N, et al. Mycobacterium haemophilim infections - New York City metropolitan area, 1990-1991. MMWR Morb Mortal Wkly Rep 1991; 40:636-37, 643.
36. Straus WL, Ostroff SM, Jernigan DB, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994; 120:118-25.
37. Tejan-Sie SA, Avery RK, Mossad SB. Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. Scand J Infect Dis 2000; 32:94-6.
38. Ozkaynak MF, Lenarsky C, Kohn D, Weinberg K, Parkman R. Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children. Am J Pediatr Hematol Oncol 1990; 12:220-4.
39. Kiehn TE, White M, Pursell KJ, et al. A cluster of four cases of Mycobacterium haemophilum infection. Eur J Clin Microbiol Infect Dis 1993; 12:114-8.
40. Mohite U, Das M, Saikia T, et al. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation. Leuk Lymphoma 2001; 40:675-8.
41. Bekassy AN, Miorner H, Hagerstrand I, Anders F. Graft failure disclosing disseminated Mycobacterium avium-intracellulare infection. Bone Marrow Transplant 1992; 10:476.
42. Busam KJ, Kiehn TE, Salob SP, Myskowski PL. Histologic reactions to cutaneous infections by Mycobacterium haemophilum. Am J Surg Pathol 1999; 23:1379-85.
43. Holland DJ, Chen SC, Chew WW, Gilbert GL. Mycobacterium neoaurum infection of a Hickman catheter in an immunosuppressed patient. Clin Infect Dis 1994; 18:1002-3.
44. Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983; 5:216-26.
45. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5:657-79.
46. Wolfson JS, Sober AJ, Rubin RH. Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 1985; 64:115-33.
47. Gombert ME, Goldstein EJ, Corrado ML, Stein AJ, Butt KM. Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 1981; 94:486-7.
48. Heironimus JD, Winn RE, Collins CB. Cutaneous nonpulmonary Mycobacterium chelonei infection. Successful treatment with sulfonamides in an immunosuppressed patient. Arch Dermatol 1984; 120:1061-3.
49. Bomalaski JS, Williamson PK, Goldstein CS. Infectious arthritis in renal transplant patients. Arthritis Rheum 1986; 29:227-32.
50. Cooper JF, Lichtenstein MJ, Graham BS, Schaffner W. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med 1989; 86:173-7.
51. Koizumi JH, Sommers HM. Mycobacterium xenopi and pulmonary disease. Am J Clin Pathol 1980; 73:826-30.
52. Fraser DW, Buxton AE, Naji A, Barker CF, Rudnick M, Weinstein AJ. Disseminated Mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis 1975; 112:125-9.
53. Davis BR, Brumbach J, Sanders WJ, Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 1982; 97:723-4.
54. Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974; 229:419-24.
55. Bolivar R, Satterwhite TK, Floyd M. Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol 1980; 116:207-8.
56. Mehta R, Oliver LD, Melillo D, Milliorn K, Flye W, Fish J. Disseminated Mycobacterium chelonei infection following cadaveric renal transplantation: favorable response to cefoxitin. Am J Kidney Dis 1983; 3:124-8.
57. Endzweig CH, Strauss E, Murphy F, Rao BK. A case of cutaneous Mycobacterium chelonae/abscessus infection in a renal transplant patient. J Cutan Med Surg 2001; 5:28-32.
58. de Jong JJ, van Gelder T, JN IJ, Endtz HP, Weimar W. Atypical Mycobacterium infection with dermatological manifestation in a renal transplant recipient. Transpl Int 1999; 12:71-3.
59. Farooqui MA, Berenson C, Lohr JW. Mycobacterium marinum infection in a renal transplant recipient. Transplantation 1999; 67:1495-6.
60. Neuman HB, Andreoni KA, Johnson MW, Fair JH, Gerber DA. Terminal ileitis secondary to Mycobacterium gordonae in a renal transplant. Transplantation 2003; 75:574-5.
61. Patel R, Roberts GD, Keating MR, Paya CV. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994; 19:263-73.
62. Argiris A, Maun N, Berliner N. Mycobacterium avium complex inclusions mimicking Gaucher's cells. N Engl J Med 1999; 340:1372.
63. Nagy GS, Rubin RH. Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient. Transpl Infect Dis 2001; 3:220-30.
64. Bernard L, Vincent V, Lortholary O, et al. Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review. Clin Infect Dis 1999; 29:1455-60.
65. Verhelst D, Goffin E, Bodarwe AD, Gigi J, Pirson Y. Purple-blue subcutaneous nodules after renal transplantation: not always Kaposi sarcoma. Nephrol Dial Transplant 2001; 16:1716-8.
66. Sanger JR, Stampfl DA, Franson TR. Recurrent granulomatous synovitis due to Mycobacterium kansasii in a renal transplant recipient. J Hand Surg [Am] 1987; 12:436-41
67. Branger B, Gouby A, Oules R, et al. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol 1985; 23:46-9.
68. Gouby A, Branger B, Oules R, Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol. 1988; 25:299-300.
69. Weber J, Mettang T, Staerz E, MachIeidt C, Kuhlmann U. Pulmonary disease due to Mycobacterium xenopi in a renal allograft recipient: report of a case and review. Rev Infect Dis 1989; 11:964-9.
70. Kochhar R, Indudhara R, Nagi B, Yadav RV, Mehta SK. Colonic tuberculosis due to atypical mycobacteria in a renal transplant recipient. Am J Gastroenterol 1988; 83:1435-6.
71. Perandones CE, Roncoroni AJ, Frega NS, Bianchini HM and Hubscher O. Mycobacterium gastri arthritis: septic arthritis due to Mycobacterium gastri in a patient with a renal transplant. J Rheumatol 1991; 18:777-8.
72. Sumrani N, Delaney V, Hong JH, Sommer BG. Mycobacterium avium-intracellulare infection of a renal allograft. Clin Nephrol 1991; 35:45-6.
73. Graybill JR, Silva J Jr, Fraser DW, Lordon R, Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis 1974; 109:4-10.
74. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996; 9:435-47.
75. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993; 16:463-71.
76. Rosen T. Cutaneous Mycobacterium kansasii infection presenting as cellulitis. Cutis 1983; 31:87-9.
77. Walder BK, Jeremy D, Charlesworth JA, Macdonald GJ, Pussell BA, Robertson MR. The skin and immunosuppression. Australas J Dermatol 1976; 17:94-7.
78. Dawson DJ, Jennis F. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol 1980; 11:190-2.
79. Murdoch ME, Leigh IM. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol 1989; 14:309-12.
80. Czachor JS, Gopalakrishnan R. Coexistent gout and Mycobacterium avium-intracellulare arthritis in a renal transplant recipient. Kidney Blood Press Res 1997; 20:62-3.
81. Jopp-McKay AG, Randell P. Sporotrichoid cutaneous infection due to Mycobacterium chelonei in a renal transplant patient. Australas J Dermatol 1990; 31:105-9.
82. Cruz N, Ramirez-Muxo O, Bermudez RH, Santiago-Delpin EA. Pulmonary infection with M. kansasii in a renal transplant patient. Nephron 1980; 26:187-8.
83. Niranjankumar MS, Georgi A, Ananth S, Anandi V, Gaspar JH. Mycobacterium fortuitum psoas abscess in a renal transplant recipient. Nephrol Dial Transplant 1994; 9:80-2.
84. Ryan CG, Dwyer BW. New characteristics of Mycobacterium haemophilum. J Clin Microbiol 1983; 18:976-7.
85. Mezo A, Jennis F, McCarthy SW, Dawson DJ. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology 1979; 11:377-84.
86. Moulsdale M, Harper JM, Thatcher GN. Unusual Mycobacterium infection in a renal transplant recipient. Med J Aust 1980; 2:450-1.
87. Abbott MR, Smith DD. Mycobacterial infections in immunosuppressed patients. Med J Aust 1981; 1:351-3.
88. Williams GV. Mycobacterium fortuitum: an unsuspected cause of synovitis and osteomyelitis. Aust N Z J Med 1980; 10:440-3.
89. Indudhara R, Kochhar R, Mehta SK, Minz M, Chugh KS, Yadav RV. Acute colitis in renal transplant recipients. Am J Gastroenterol 1990; 85:964-8.
90. Paull DE, Decker GR, Brown RL. Mycobacterium kansasii empyema in a renal transplant recipient case report and review of the literature. Transplantation 2003; 76:270-1.
91. Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez-Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9:518-25.
92. Bartralot R, Pujol RM, Garcia-Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol 2000; 27:124-9.
93. Woo MS, Downey S, Inderlied CB, Kaminsky C, Ross LA, Rowland J. Pediatric transplant grand rounds: a case presentation: skin lesions in a post-lung transplant patient. Pediatr Transplant 1997; 1:163-70.
94. Swetter SM, Kindel SE, Smoller BR. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol 1993; 28:352-5.
95. Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001; 39:816-9.
96. Baldi S, Rapellino M, Ruffini E, Cavallo A, Mancuso M. Atypical mycobacteriosis in a lung transplant recipient. Eur Respir J 1997; 10: 952-4.
97. Torres F, Hodges T, Zamora MR. Mycobacterium marinum infection in a lung transplant recipient. J Heart Lung Transplant 2001; 20:486-9.
98. Fairhurst RM, Kubak BM, Shpiner RB, Levine MS, Pegues DA, Ardehali A. Mycobacterium abscessus empyema in a lung transplant recipient. J Heart Lung Transplant 2002; 21:391-4.
99. Fairhurst RM, Kubak BM, Pegues DA, et al. Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant 2002; 2:476-9.
100. Ray R, Chakravorty S, Tyagi JS, et al. Fatal atypical mycobacterial infection in a cardiac transplant recipient. Indian Heart J 2001; 53:100-3.
101. Zappe CH, Barlow D, Zappe H, Bolton IJ, Roditi D, Steyn LM. 16S rRNA Sequence analysis of an isolate of Mycobacterium haemophilum from a heart transplant patient. J Med Microbiol 1995; 43:189-91.
102. Wood C, Nickoloff BJ, Todes-Taylor NR. Pseudotumor resulting from atypical mycobacterial infection: a "histoid" variety of Mycobacterium avium-intracellulare complex infection. Am J Clin Pathol 1985; 83:524-7.
103. Neeley SP, Denning DW. Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient. Rev Infect Dis 1989; 11:608-11.
104. Plemmons RM, McAllister CK, Garces MC, Ward RL. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. Clin Infect Dis 1997; 24:995-7.
105. Lederman C, Spitz JL, Scully B, et al. Mycobacterium haemophilum cellulitis in a heart transplant recipient. J Am Acad Dermatol 1994; 30:804-6.
106. Stengem J, Grande KK, Hsu S. Localized primary cutaneous Mycobacterium kansasii infection in an immunocompromised patient. J Am Acad Dermatol 1999; 41:854-6.
107. Cooper DK, Lanza RP, Oliver S, et al. Infectious complications after heart transplantation. Thorax 1983; 38:822-8.
108. Guex AC RA, Bucher HC. Intestinal involvement by nontuberculous mycobacteria after heart transplantation. Clin Infect Dis 2000; 30:603-5.
109. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995; 20:443-4.
110. LeMense GP, VanBakel AB, Crumbley AJ 3rd, Judson MA. Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipient. Chest 1994; 106:1918-20.
111. Simpson GL, Raffin TA, Remington JS. Association of prior nocardiosis and subsequent occurrence of nontuberculous mycobacteriosis in a defined, immunosuppressed population. J Infect Dis 1982; 146:211-9.
112. Clark D, Lambert CM, Palmer K, Strachan R, Nuki G. Monoarthritis caused by Mycobacterium avium complex in a liver transplant recipient. Br J Rheumatol 1993; 32:1099-100.
113. Nathan DL, Singh S, Kestenbaum TM, Casparian JM. Cutaneous Mycobacterium chelonae in a liver transplant patient. J Am Acad Dermatol 2000; 43:333-6.
114. Chastain MA, Buckley J, Russo GG. Mycobacterium chelonae/abscessus complex infection in a liver transplant patient. Int J Dermatol 2001; 40:769-74.
115. Neau-Cransac M, Dupon M, Carles J, Le Bail B, Saric J. Disseminated Mycobacterium avium infection after liver transplantation. Eur J Clin Microbiol Infect Dis 1998; 17:744-6.
116. Hoff E, Sholtis M, Procop G, et al. Mycobacterium triplex infection in a liver transplant patient. J Clin Microbiol 2001; 39:2033-4.
117. McDiarmid SV, Blumberg DA, Remotti H, et al. Mycobacterial infections after pediatric liver transplantation: a report of three cases and review of the literature. J Pediatr Gastroenterol Nutr 1995; 20:425-31.
118. Trulock EP, Bolman RM, Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis 1989; 140:802-5.
119. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166:405-12.
120. Isono SS, Woolson ST, Schurman DJ. Total joint arthroplasty for steroid-induced osteonecrosis in cardiac transplant patients. Clin Orthop 1987 217:201-8.
121. Schmekal B, Janko O, Zazgornik J, et al. Skin tuberculosis with atypical mycobacteria 8 years after combined pancreas-kidney transplantation. Am J Nephrol 2002; 22:566-8.
122. Wallace RJ Jr, J. G, Griffith DE, Olivier KN, Cook JL, Gordin F. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156:S1-25.
123. Heifets L. Susceptibility testing of Mycobacterium avium complex isolates. Antimicrob Agents Chemother 1996; 40:1759-67.
124. Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverblatt J. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev Infect Dis 1981; 3:1035-9.
125. Wallace RJ Jr, Dunbar D, Brown BA, et al. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 1994; 18:736-43.
126. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001; 33:330-7.
127. Wallace RJ Jr, Brown BA, Griffith DE, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994; 149:1335-41.
128. Young LS, Wiviott L, Wu M, Kolonoski P, Bolan R, Inderlied CB. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991; 338:1107-9.
129. Dautzenberg B, Saint Marc T, Meyohas MC, et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1993; 153:368-72.
130. Dautzenberg B, Truffot C, Legris S, et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome: a controlled clinical trial. Am Rev Respir Dis 1991; 144:564-9.
131. Chaisson RE, Benson CA, Dube MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: arandomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med 1994; 121:905-11.
132. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991; 35:773-5.
133. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28:807-11.
134. Stone MS, Wallace RJ Jr, Swenson JM, Thornsberry C, Christensen LA. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother 1983; 24:486-93.
135. Brown BA, Wallace RJ Jr, Onyi GO. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother 1992; 36:1987-90.
136. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46:3164-7.
137. Aberg JA, Williams PL, Liu T, et al. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis 2003; 187:1046-52.
138. Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996; 335:384-91.
139. Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. N Engl J Med 1996; 335:392-8.
140. Oldfield EC, 3rd, Fessel WJ, Dunne MW, et al. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin Infect Dis 1998; 26:611-9.
141. Benson CA, Williams PL, Cohn DL, et al. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: a randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. J Infect Dis 2000; 181:1289-97.
142. United Network for Organ Sharing. Transplants by diagnosis: UNOS/OPTN data, 31 January 2003.
143. Aitken ML, Burke W, McDonald G, Wallis C, Ramsey B, Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest 1993; 103:1096-9.
144. Fauroux B, Delaisi B, Clement A, et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 1997; 16:354-8.
145. Hjelte L, Petrini B, Kallenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990; 45:397-400.
146. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 1992; 102:70-5.
147. Oliver A, Maiz L, Canton R, Escobar H, Baquero F, Gomez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 2001; 32:1298-303.
148. Kinney JS, Little BJ, Yolken RH, Rosenstein BJ. Mycobacterium avium complex in a patient with cystic fibrosis: disease vs. colonization. Pediatr Infect Dis J 1989; 8:393-6.
149. Cullen AR, Cannon CL, Mark EJ, Colin AA. Mycobacterium abscessus infection in cystic fibrosis: colonization or infection? Am J Respir Crit Care Med 2000; 161:641-5.
150. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 1994; 149:1601-7.
151. Hermida G, Richard C, Baro J, et al. Allogeneic BMT in a patient with CML and prior disseminated infection by Mycobacterium avium complex. Bone Marrow Transplant 1995; 16:183-5.